First-line bevacizumab in combination with chemotherapy for HER2-negative metastatic breast cancer: pooled and subgroup analyses of data from 2447 patients

✍ Scribed by Miles, D. W.; Dieras, V.; Cortes, J.; Duenne, A.- A.; Yi, J.; O'Shaughnessy, J.

• Book ID: 121345216
• Publisher: Oxford University Press
• Year: 2013
• Tongue: English
• Weight: 426 KB
• Volume: 24
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdt276